Opiate Dependence
Conditions
Keywords
opiate dependence, substitution treatment, unsupervised dosing, monitoring
Brief summary
The purpose of this study is to improve unsupervised dosing of opioid substitution medications. The aim of the study is to examine whether electronic compliance monitoring provides some advantages to patients'treatment and what kind of patients especially benefit from monitoring. We would also like to know if electronic compliance monitoring can prevent the abuse/diversion of medications and how implementing this method to wider treatment facilities succeeds.
Interventions
Patients get all their unsupervised substitution medication doses in electronic monitoring devices during the study. Daily dose of the drug is possible to get from the device in given time points and in the meantime device is locked.
Sponsors
Study design
Eligibility
Inclusion criteria
* opiate dependence F11.22 according to ICD-10 * Suboxone treatment * the duration of substitution treatment before study at least one month * stable medication dose
Exclusion criteria
* unstable situation in life according to treatment staff's opinions
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The effectiveness of treatment (Treatment Outcomes Profile TOP) | Every two months. | Structured interview designed to measure the effectiveness and outcomes of opioid substitution treatment. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patients´opinions about the treatment. | Once when the study phase ends (after four months). | Questionnaire designed for this study to explore patients' opinions on the compliance monitoring and it's effect on their treatment and abuse and/or diversion of medications. |
Countries
Finland